Business Wire

CA-TALKDESK

9.5.2024 07:01:35 CEST | Business Wire | Press release

Share
Talkdesk Hires Simon Horrocks as Asia-Pacific Leader to Turbocharge the Company’s Regional Growth as Artificial Intelligence Innovator

Talkdesk®, Inc., a global AI-powered contact center leader for enterprises of all sizes, today announced that Simon Horrocks has joined Talkdesk as the Asia-Pacific (APAC) leader to help drive the company’s ongoing growth and expansion as an artificial intelligence (AI) leader in customer experience (CX).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240508118657/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Simon Horrocks, Vice President of APAC at Talkdesk (Photo: Business Wire)

Horrocks joins Talkdesk with over 30 years of sales experience managing teams for startups and large organizations in APAC. Based in Sydney, Australia, he is focused on go-to-market acceleration and business expansion for Talkdesk in Australia and New Zealand (ANZ) and Southeast Asia. Horrocks’ appointment further highlights the company’s commitment to being an AI-first CX leader in APAC, as Talkdesk finalizes plans for a regional cloud in Australia and additional regional expansion.

Horrocks joined Talkdesk from Harness.io, where he led the charge in the APAC market as the U.S.-based software delivery platform start-up looked to make its mark in the region. Previously, he worked with several leading and prominent technology companies in APAC, including, AppDynamics, Cisco, IBM, and ScienceLogic.

In addition to Horrocks’ hire, Talkdesk recently promoted Miles Ennis to global sales leader and announced Munil Shah as the company’s chief technology officer (CTO). The appointments follow recent news of Talkdesk launching several groundbreaking and industry-first generative artificial intelligence (GenAI) innovations in CX, including Talkdesk Ascend Connect, Talkdesk Autopilot for Banking, Talkdesk Autopilot for Retail, and Talkdesk Autopilot for Healthcare. Under these new leaders, Talkdesk will capitalize on an extensive global opportunity as companies look to the power of GenAI to help them innovate and expand their businesses, improve customer experiences, and streamline operations.

Talkdesk operates at the forefront of the CX industry, helping companies globally to benefit from a new era of automation and intelligence with contact center solutions powered by Talkdesk AI.

The company was named a Leader in the G2 Spring 2024 Grid® Report for Contact Center category with over 1,800 five-star reviews and ranked #1 in multiple categories, including Enterprise Results and Usability Index for Contact Center Workforce, based on customers’ authentic feedback. Most recently, TrustRadius recognized Talkdesk with 2024 Top Rated Awards for contact center, call center workforce optimization, call recording, and voice over Internet Protocol (VoIP).

Supporting Quotes

William Welch, president and chief operating officer of Talkdesk, said, “APAC is an important market for Talkdesk. With Simon in this critical leadership position in our sales organization, we can drive further growth and success in the region. GenAI offers unparalleled opportunities for companies to elevate customer experience, and Talkdesk will be able to help more organizations globally to reap the benefits.”

Simon Horrocks, vice president of APAC at Talkdesk, commented: “Talkdesk is at the forefront of GenAI innovations in the contact center at a time when businesses need to deliver seamless CX more than ever. Talkdesk is already used by some of the largest banks, e-tailers, and BPOs in APAC, and I’m honored to join the company at such an exciting time, to continue the company’s global expansion momentum.”

About Talkdesk

Talkdesk® is a global cloud contact center leader for enterprises of all sizes. Talkdesk CX Cloud and Industry Experience Clouds help enterprises deliver modern customer service their way. Our trusted, flexible, and innovative contact center platform leverages AI and automation to drive exceptional outcomes for their customers and improve the bottom line. Serving enterprise customers in over 100 countries, we partner with our customers to deliver continuous innovation and breakthrough results. Our unwavering commitment to doing what we say we will do and our investment in the highest levels of security and reliability for our products make us second to none in the industry. Improve customer experiences, increase efficiency, and grow revenue with Talkdesk, a cloud contact center platform built for your industry. Learn more and take a self-guided demo at www.talkdesk.com.

Talkdesk is a registered trademark of Talkdesk, Inc. All product and company names are trademarks or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240508118657/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release

- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur

Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release

Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i

Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release

Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different

Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 14:00:00 CET | Press release

A domain-trained AI agent workforce enables production-scale AI across regulated financial institution operations Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye